Yong-Guo Li
Overview
Explore the profile of Yong-Guo Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding B, Wu Y, Zhang Y, Li Y
Medicine (Baltimore)
. 2024 Aug;
103(32):e39233.
PMID: 39121295
Epstein-Barr virus (EBV) infects over 95% of the global population and is strongly associated with various autoimmune diseases. Anti-nuclear antibodies (ANA) serve as valuable laboratory biomarkers for screening and supporting...
2.
Zou B, Ding S, Ru L, An F, Li Y
Am J Case Rep
. 2024 Jul;
25():e944543.
PMID: 39054659
BACKGROUND Odontogenic keratocyst (OKC) is a common odontogenic cyst, and it occurs more frequently in the mandible, with the posterior region of the dental arch, the angle, or the ramus...
3.
Zheng Y, Zhang H, Zhan Y, Bian Y, Ma S, Gan H, et al.
Acta Pharmacol Sin
. 2023 Aug;
44(12):2549.
PMID: 37532785
No abstract available.
4.
Zhang L, Sun H, Liu Y, Lai X, Gong Y, Liu X, et al.
Eur J Pharm Sci
. 2022 Jul;
177:106264.
PMID: 35868434
Aims: Vicagrel is a novel antiplatelet drug used to mitigate clopidogrel resistance due to CYP2C19 polymorphism. This study aimed to develop a semi-mechanistic population pharmacokinetic (PopPK) model to characterize the...
5.
Wu Q, Wang Q, Guo G, Li Y, Xing Y, Zhao M, et al.
J Forensic Leg Med
. 2022 Jun;
90:102374.
PMID: 35667313
The report is about a 49-year-old man with rheumatic heart disease and atrial fibrillation. He underwent mitral valve replacement, tricuspid valvuloplasty, and atrial fibrillation radiofrequency ablation in the hospital. He...
6.
Yao R, Wang B, Fu L, Li L, You K, Li Y, et al.
Microbiol Spectr
. 2022 Feb;
10(1):e0247721.
PMID: 35170994
Bedaquiline (BDQ) was historically listed by the World Health Organization (WHO) in 2018 as the preferred option for rifampin-resistant tuberculosis (RR-TB) and multidrug-resistant tuberculosis (MDR-TB). However, when there is no...
7.
Li P, Yang Y, Li Y, Sun S
Mitochondrial DNA B Resour
. 2021 Jan;
3(2):1263-1264.
PMID: 33474486
In the present study, the complete mitochondrial genome of was determined using the next-generation sequencing. The circular genome was found to be 15,254 bp in length and had an overall...
8.
Zhang L, Weng T, Wang H, Sun F, Liu Y, Lin K, et al.
Clin Microbiol Infect
. 2021 Jan;
27(7):1000-1006.
PMID: 33421578
Objectives: Delay in diagnosis of tuberculosis (TB) is an important but under-appreciated problem. Our study aimed to analyse the patient pathway and possible risk factors of long diagnostic delay (LDD)....
9.
Zheng Y, Zhang H, Zhan Y, Bian Y, Ma S, Gan H, et al.
Acta Pharmacol Sin
. 2020 Nov;
42(9):1535-1546.
PMID: 33244163
Vicagrel, a novel irreversible P2Y receptor inhibitor, is undergoing phase III trials for the treatment of acute coronary syndromes in China. In this study, we evaluated the pharmacokinetics, mass balance,...
10.
Tang L, Zhou Y, Zhu S, Liang G, Zhuang H, Zhao M, et al.
BMC Med Genomics
. 2020 Apr;
13(1):59.
PMID: 32252754
Background: Escherichia coli are mostly commensals but also contain pathogenic lineages. It is largely unclear whether the commensal E. coli as the potential origins of pathogenic lineages may consist of...